46,132 Shares in Sotera Health Company $SHC Acquired by AlphaQuest LLC

Key Points

• AlphaQuest LLC has acquired 46,132 shares of Sotera Health Company, valued at approximately $538,000, marking a significant investment in the company during the 1st quarter.
• Several institutional investors have increased their holdings in Sotera Health, with T. Rowe Price boosting its shares by 5.9% and Two Seas Capital increasing by a staggering 624.0%.
• Analyst ratings for Sotera Health have improved, with Goldman Sachs upgrading the stock to a buy and raising the price target from $14.00 to $17.00, indicating positive market sentiment.

AlphaQuest LLC acquired a new stake in shares of Sotera Health Company (NASDAQ:SHC - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 46,132 shares of the company's stock, valued at approximately $538,000.

Several other institutional investors have also recently modified their holdings of the company. T. Rowe Price Investment Management Inc. increased its position in shares of Sotera Health by 5.9% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 8,045,502 shares of the company's stock valued at $93,811,000 after purchasing an additional 450,761 shares during the last quarter. Sculptor Capital LP bought a new position in shares of Sotera Health during the 4th quarter valued at about $68,400,000. Dimensional Fund Advisors LP increased its position in shares of Sotera Health by 27.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock valued at $43,004,000 after purchasing an additional 673,979 shares during the last quarter. Irenic Capital Management LP increased its position in shares of Sotera Health by 4.3% during the 4th quarter. Irenic Capital Management LP now owns 2,909,163 shares of the company's stock valued at $39,797,000 after purchasing an additional 120,832 shares during the last quarter. Finally, Two Seas Capital LP increased its position in shares of Sotera Health by 624.0% during the 4th quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock valued at $39,619,000 after purchasing an additional 2,496,136 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on SHC. Barclays reiterated an "overweight" rating on shares of Sotera Health in a research report on Friday, August 8th. Wall Street Zen raised Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Finally, The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $14.00 to $17.00 in a research note on Monday, May 5th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $16.00.

Sotera Health Price Performance

Shares of Sotera Health stock opened at $16.39 on Tuesday. The firm has a market cap of $4.66 billion, a PE ratio of 204.90 and a beta of 1.81. Sotera Health Company has a 12-month low of $9.53 and a 12-month high of $17.08. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. The company's fifty day simple moving average is $12.45 and its two-hundred day simple moving average is $12.17.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. The business had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The company's revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, equities analysts expect that Sotera Health Company will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.